InsidersTradesSigma
Follow the LongBio Pharma (Suzhou) Co., Ltd. - B - H Shares stock price and the full insider trade history of the company, a listed issuer based in Hong Kong. Shares are listed on the HK market, under the oversight of HKEX. Market capitalisation: €8.8bn. The latest transaction was reported on 23 June 2026 (Other). Among the most active insiders: LIU Heng. Every trade is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
LongBio Pharma (Suzhou) Co., Ltd. es una empresa farmacéutica centrada en el desarrollo de tratamientos biológicos. Cotiza en la categoría de acciones B en Hong Kong.